Streetbeat News

Equity Actions

KULR

KULR Technology Group Inc has entered into a letter agreement with investment firm Ya II PN, Ltd, according to a recent SEC filing.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:20 pm

CGC

Canopy Growth has initiated a private placement with institutional investors, issuing 6,993,007 units at a price of $4.29 each, resulting in aggregate gross proceeds of $30 million. This strategic move aims to raise capital for the company, potentially for growth initiatives, debt reduction, or other corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:15 pm

ABL

Abacus Life, Inc. (NASDAQ:ABL) has repurchased 206,050 shares at an average price of $9.26, spending approximately $1.9 million in the first 30 days of its $15 million stock repurchase program. The program, which began on December 12, 2023, has $13.1 million remaining and will expire on June 10, 2025. The company's CEO, Jay Jackson, expressed confidence in the business and its growth initiatives. Repurchases may continue through various methods and will be funded by cash on hand and future free cash flow.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:15 pm

EFTR

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) has announced a 1-for-25 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective on January 12, 2024, reducing the number of outstanding shares from approximately 74.9 million to 3.0 million. The company's common stock will continue trading under the symbol 'EFTR' with a new CUSIP number. No fractional shares will be issued; instead, shareholders will receive a cash payment for fractional entitlements.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:10 pm

ESTA

Establishment Labs Holdings Inc. has announced a $50 million private placement. The company, which is known for its innovative medical technology, particularly in the aesthetic space, plans to use the proceeds from the private placement to fund its operations and growth initiatives. This influx of capital is expected to strengthen the company's financial position and support its strategic business objectives.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:07 pm

CATX

LNTH

Lantheus Holdings, Inc. has agreed to acquire an equity stake of up to 19.9% in Perspective's outstanding shares, with the transaction valued at approximately $33 million.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:06 pm

LSEA

Landsea Homes Corporation has completed the acquisition of Antares Homes for $232.2 million, significantly expanding its presence in the Texas housing market. This strategic move is expected to enhance Landsea Homes' product offerings and market reach in the region.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:05 pm

BA

COIN

JNPR

Analysts predict Bitcoin ETFs could face premiums up to 8% amid high anticipation and lobbying efforts for approval. Cathie Wood's ARK Invest halts Coinbase selling and invests $8M in a chip giant. Emirates President highlights Boeing's quality control issues after a 737 Max 9 incident. Jim Cramer believes Bitcoin is topping out as ETF approval nears. Solana-based meme coin Bonk surges 30%. Former SEC Chair Jay Clayton sees Bitcoin ETF approval as inevitable. Juniper Networks' stock surges on news of a potential $13B acquisition by Hewlett Packard Enterprise.

Portfolio Pulse from Akanksha Bakshi

January 09, 2024 | 12:47 pm

CCM

Concord Medical Services announced plans to list its subsidiary on the Stock Exchange of Hong Kong, expecting to raise HK$562.9M (approximately $72.2M) from the initial public offering.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:14 pm

DTIL

TGTX

Precision BioSciences, Inc. (DTIL) has completed a strategic transaction with TG Therapeutics, Inc. (TGTX), granting TGTX an exclusive license to develop Azercabtagene Zapreleucel (azer-cel) for autoimmune diseases. The deal includes an upfront payment and potential near-term economics valued at $17.5 million, with Precision eligible for up to $288 million in future milestones and royalties on net sales. TGTX will also make an equity investment in Precision by purchasing shares at a 100% premium to the 30-day VWAP.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 12:05 pm